KSRelief signs three projects to fight cholera in Yemen

KSRelief Supervisor General Dr. Abdullah Al-Rabeeah


:: The King Salman Humanitarian Aid and Relief Center (KSRelief) signed three humanitarian projects on Tuesday worth $11 million with the World Health Organization (WHO) to combat and eradicate the cholera epidemic in Yemen.

This initiative was taken by Crown Prince Mohammed bin Salman, who had already pledged $66.7 million to fight the epidemic in partnership with WHO and UNICEF.

The three signed projects cover diagnosis, prevention, and monitoring steps, all of which are important in preventing and combating cholera. On Nov. 14, 2017, two projects of $23 million were signed for treatment and coordination.

KSRelief Supervisor General Dr. Abdullah Al-Rabeeah expressed his pleasure as his organization is continuing to carry out its plan of comprehensive humanitarian operations serving the Yemeni people.

He said the monitoring project will focus on expanding the early-warning system of monitoring cholera, to ensure coordination, immediate reports of cholera cases, lab test results, confirmation and responding mechanisms. The project covers all 23 Yemeni governorates.

The prevention project will focus on launching awareness campaigns on audiovisual and social media platforms, as well as intensifying operations to identify suspicious cases, referring them to medical facilities, specifying the most affected areas in order to carry out the vaccination campaign, training medical staff on how to prevent infections, and providing 400,000 cholera vaccinations.

Dr. Ibrahim Al-Zeik, on behalf of WHO, thanked the Kingdom for the continuous humanitarian support it provides to the world, and especially to Yemen.













Saudi Telecom Academy promises a new generation of digital leaders
King Salman’s call for cultural diversity wins praise
%d bloggers like this:
Powered by : © 2014 Systron Micronix :: Leaders in Web Hosting. All rights reserved

| About Us | Privacy Policy | Terms of Use | Disclaimer | Contact Us |